A Phase 1, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics of Iberdomide in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared with Healthy Subjects

• Главные авторы: Cheng Y (Автор), Ye Y (Автор), Gaudy A (Автор), Ghosh A (Автор), Xue Y (Автор), Wang A (Автор), Zhou S (Автор), Li Y (Автор)
• Формат: ‌
• Опубликовано: Dove Medical Press, 2023-02-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Yiming Cheng,1 Ying Ye,1 Allison Gaudy,1 Atalanta Ghosh,2 Yongjun Xue,3 Alice Wang,1 Simon Zhou,1 Yan Li1 1Clinical Pharmacology & Pharmacometrics, Bristol Myers Squibb, Princeton, NJ, USA; 2Global Biometrics and Data Sciences, Bristol Myers Squibb, Princeton, NJ, USA; 3Nonclinical Research &...